-
FDA has approved new indications for Janssen's risperidone (Risperdal®) for treating schizophrenia in adolescents ages 13-17 and for the short-term treatment of manic or mixed episodes of bipolar 1 disorder in children and adolescents ages 10-17.
-
Rotigotine (Neupro®) is a new transdermal dopamine agonist.
-
-
Taking a step-by-step approach to implementing pharmacist-managed ambulatory clinics can lead to success.
-
To enhance patient learning and increase patients' access to books and resources available at M.D. Anderson Cancer Center in Houston, a patient education office communication plan has been established.
-
Expectant mothers receive a lot of information over the course of their pregnancy and are sometimes inundated with things to remember. Yet one important message that needs to be stressed is that some may experience postpartum mood disorders that can adversely affect their mental health.
-
If your hospital is having difficulty complying with the new Medicare rule for notifying patients of their right to appeal their discharge, you're not alone.
-
As the baby boomers age, creating a huge influx of Medicare recipients, health care providers are going to be challenged to provide coordinated care for the elderly as they move through the fragmented health care system.
-
Creating a patient education culture within an institution will help ensure that teaching is part of the care that is provided, not an afterthought or something that is completed if there is time.
-
The "yes means no" phenomenon was one of several challenges encountered by the team conducting a community case management pilot project for diabetes patients in Nogales, AZ, says Donna Zazworsky, RN, MS, CCM, FAAN, diabetes care center manager for the Tucson-based Carondelet Health Network.
